Charles River Laboratories International CRL
NYSE CRL
$296.78 +1.68 (+0.57%)
As of: Aug 27, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Income from Discontinued Operations (2009 - 2018)

Charles River Laboratories International (CRL) posted quarterly Income from Discontinued Operations of 42000.0 for Q3 2011, up 111.41% year-over-year from 19866.32 in Q3 2010, and up 103.45% quarter-over-quarter from 1219000.0 in Q2 2011.

Charles River Laboratories International (CRL) Income from Discontinued Operations (2009 - 2018) Analysis & Trends

Charles River Laboratories International's Income from Discontinued Operations history runs 2 years deep, the most recent figure standing at 42000.0 for Q3 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn -
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -
10 Charles River Laboratories International 14.28 Bn 14.09 Bn 452.07 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2018 1.53 Mn
Mar 31, 2018 -23,000.00
Dec 30, 2017 -23,000.00
Sep 30, 2017 -39,000.00
Jul 1, 2017 -71,000.00
Apr 1, 2017 -4,000.00
Dec 31, 2016 -48,000.00
Sep 24, 2016 342,000.00
Jun 25, 2016 12,000.00
Mar 26, 2016 -26,000.00
Dec 26, 2015 -902,000.00
Sep 26, 2015 -34,000.00
Jun 27, 2015 -7,000.00
Mar 28, 2015 -7,000.00
Dec 27, 2014 -864,000.00
Sep 27, 2014 52,000.00
Jun 28, 2014 -644,000.00
Mar 29, 2014 -270,000.00
Dec 28, 2013 -82,000.00
Sep 28, 2013 -113,000.00